Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Sansom

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Pharmacology|January 1, 1981
A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remissionJ D Arnold, G N Hill, L N Sansom
Biochemical and Biophysical Research Communications|January 30, 1990
Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomesC J Doecke, L N Sansom, M E McManus
Australian and New Zealand Journal of Public Health|January 21, 2000
'Pharmacist only' medicinesT L Bessell, J E Hiller, L N Sansom
British Journal of Clinical Pharmacology|August 1, 1989
Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofenA M Evans, R L Nation, L N Sansom
The Medical Journal of Australia|November 11, 1972
A problem when ampoules are openedD T Burke, K S Porter, L N Sansom
Antimicrobial Agents and Chemotherapy|August 1, 1985
Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administrationT E Jones, R W Milne, Y Mudaliar, et al.
Biochemical and Biophysical Research Communications|April 30, 1993
Molecular characterisation of a human aryl sulfotransferase cDNAX Zhu, M E Veronese, L N Sansom, et al.
The Journal of Pharmacy and Pharmacology|April 1, 1996
The effects of cyclophosphamide on the pharmacokinetics of triiodothyronine in the male ratM T Angley, L N Sansom, T C Smeaton, et al.
Pharmaceutica Acta Helvetiae|January 1, 1976
Some aspects of the stability of parenteral nutrition solutionsK R West, L N Sansom, D G Cosh, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Hospitalization rates as outcome indicators of national medicinal drug policies: the example of gastrointestinal ulcerE E Roughead, A L Gilbert, J G Primrose, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 1, 1981
A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remissionJ D Arnold, G N Hill, L N Sansom
Biochemical and Biophysical Research Communications|January 30, 1990
Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomesC J Doecke, L N Sansom, M E McManus
Australian and New Zealand Journal of Public Health|January 21, 2000
'Pharmacist only' medicinesT L Bessell, J E Hiller, L N Sansom
British Journal of Clinical Pharmacology|August 1, 1989
Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofenA M Evans, R L Nation, L N Sansom
The Medical Journal of Australia|November 11, 1972
A problem when ampoules are openedD T Burke, K S Porter, L N Sansom
Antimicrobial Agents and Chemotherapy|August 1, 1985
Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administrationT E Jones, R W Milne, Y Mudaliar, et al.
Biochemical and Biophysical Research Communications|April 30, 1993
Molecular characterisation of a human aryl sulfotransferase cDNAX Zhu, M E Veronese, L N Sansom, et al.
The Journal of Pharmacy and Pharmacology|April 1, 1996
The effects of cyclophosphamide on the pharmacokinetics of triiodothyronine in the male ratM T Angley, L N Sansom, T C Smeaton, et al.
Pharmaceutica Acta Helvetiae|January 1, 1976
Some aspects of the stability of parenteral nutrition solutionsK R West, L N Sansom, D G Cosh, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Hospitalization rates as outcome indicators of national medicinal drug policies: the example of gastrointestinal ulcerE E Roughead, A L Gilbert, J G Primrose, et al.
Pageof 5